Rhumbline Advisers Sells 18,549 Shares of DaVita Inc. (NYSE:DVA)

Rhumbline Advisers decreased its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 12.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 134,125 shares of the company's stock after selling 18,549 shares during the quarter. Rhumbline Advisers owned approximately 0.16% of DaVita worth $20,058,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in DaVita in the 4th quarter worth approximately $597,000. Summit Trail Advisors LLC lifted its holdings in shares of DaVita by 9.0% in the fourth quarter. Summit Trail Advisors LLC now owns 25,416 shares of the company's stock worth $3,801,000 after buying an additional 2,107 shares in the last quarter. Wingate Wealth Advisors Inc. bought a new position in shares of DaVita during the fourth quarter worth $82,000. Empowered Funds LLC grew its stake in DaVita by 856.4% during the fourth quarter. Empowered Funds LLC now owns 55,698 shares of the company's stock valued at $8,330,000 after acquiring an additional 49,874 shares in the last quarter. Finally, Strategic Financial Concepts LLC bought a new stake in DaVita in the 4th quarter valued at $9,371,000. Institutional investors own 90.12% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Barclays increased their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, DaVita presently has a consensus rating of "Hold" and a consensus price target of $162.80.

DaVita Price Performance

DaVita stock traded down $3.59 during mid-day trading on Friday, reaching $142.33. 1,605,084 shares of the company's stock traded hands, compared to its average volume of 845,867. DaVita Inc. has a 12-month low of $120.78 and a 12-month high of $179.60. The company has a market cap of $11.39 billion, a price-to-earnings ratio of 13.25, a PEG ratio of 1.14 and a beta of 0.94. The stock has a 50 day moving average of $161.24 and a two-hundred day moving average of $157.81. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.